Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Uterine Cervical Neoplasms 13Prostatic Neoplasms 6Sarcoma 4Breast Neoplasms 4Radiation Injuries 2Carcinoma, Ductal, Breast 2Obesity 1Neurotoxicity Syndromes 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms 1Fatigue 1Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation 1Endometrial Clear Cell Adenocarcinoma 1Drug-Related Side Effects and Adverse Reactions 1Carcinoma, Intraductal, Noninfiltrating 1Breast Carcinoma In Situ 1Anemia 1

Interventions

Etoposide 6Ifosfamide 5Vincristine 4Radiotherapy 4Granulocyte Colony-Stimulating Factor 4Filgrastim 4Doxorubicin 4Cyclophosphamide 4Topotecan 2trioctyl phosphine oxide 1indolepropanol phosphate 1imetelstat 1etoposide phosphate 1Vinorelbine 1Vinblastine 1Trabectedin 1Thrombopoietin 1Radiosurgery 1Radiation 1Polymerase Chain Reaction 1Neoadjuvant Therapy 1Microarray Analysis 1Mesna 1MLN 8237 1Irinotecan 1Immunohistochemistry 1Glutamine 1Gene Expression Profiling 1GRN163L peptide 1Electroacupuncture 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Neuroectodermal Tumors, Primitive, Peripheral × Brachytherapy × Clear all
NCT00006734 2023-08-03

Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor

Children's Oncology Group

Phase 3 Completed
587 enrolled
Sarcoma

Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡